tiprankstipranks
Trending News
More News >
United Therapeutics (UTHR)
NASDAQ:UTHR

Compare United Therapeutics (UTHR) vs. Competitors

Compare
679 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
United Therapeutics
$482.59
$20.78B
18.29
36.54%
4 Buy
2 Hold
0 Sell
Moderate Buy
BioMarin Pharmaceutical
$57.62
$11.07B
21.59
-8.35%
8 Buy
5 Hold
0 Sell
Moderate Buy
Exelixis
$42.65
$11.43B
17.96
28.77%
4 Buy
6 Hold
1 Sell
Moderate Buy
Incyte
$102.60
$20.14B
17.21
38.42%
7 Buy
8 Hold
1 Sell
Moderate Buy
Ascendis Pharma
$219.73
$13.43B
-51.74
79.74%
13 Buy
0 Hold
0 Sell
Strong Buy
Genmab
$31.90
$19.53B
13.44
66.06%
5 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
UTHR
United Therapeutics
482.59
128.84
36.42%
BMRN
BioMarin Pharmaceutical
57.62
-6.72
-10.44%
EXEL
Exelixis
42.65
8.98
26.67%
INCY
Incyte
102.60
27.65
36.89%
ASND
Ascendis Pharma
219.73
94.71
75.76%
GMAB
Genmab
31.90
12.55
64.86%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts